Target Name: MIR29B2
NCBI ID: G407025
Review Report on MIR29B2 Target / Biomarker Content of Review Report on MIR29B2 Target / Biomarker
MIR29B2
Other Name(s): MIRN29B2 | hsa-miR-29b-2-5p | hsa-miR-29b-3p | hsa-mir-29b-2 | microRNA 29b-2 | MicroRNA 29b-2 | mir-29b-2

MIR29B2: A Potential Drug Target and Biomarker

MIR29B2, a gene located on chromosome 1p36.1, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its function in the body and its potential as a drug target are of great interest to researchers and doctors, as it may provide new insights into the underlying mechanisms of these diseases and the development of new treatments.

MIR29B2 is a non-coding RNA molecule that is expressed in various tissues and cells of the body. It is a part of the microRNA (miRNA) family, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation . MIR29B2 is known for its ability to interact with multiple protein molecules, including targets such as XPC and AGO2, which are involved in the regulation of gene expression and cell survival, respectively.

Studies have shown that MIR29B2 is involved in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to play a role in the regulation of cell cycle progression, and has been linked to the development of various diseases, including cancer . For example, MIR29B2 has been shown to be downregulated in various types of cancer, and its overexpression has been shown to promote the growth and survival of cancer cells.

In addition to its role in cancer, MIR29B2 has also been linked to the development of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Studies have shown that MIR29B2 is involved in the regulation of neurodegenerate protein synthesis and has been implicated in the pathogenesis of these disorders.

Furthermore, MIR29B2 has also been shown to be involved in the regulation of immune responses, which is of great interest in the development of autoimmune diseases. Studies have shown that MIR29B2 is involved in the regulation of T cell function and has been implicated in the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

In conclusion, MIR29B2 is a non-coding RNA molecule that has been shown to be involved in various cellular processes and has been linked to the development of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its potential as a drug target and biomarker makes it an attractive target for researchers and doctors to study and develop new treatments for these diseases. Further studies are needed to fully understand the role of MIR29B2 in the development of these diseases and its potential as a drug.

Protein Name: MicroRNA 29b-2

The "MIR29B2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR29B2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174